AriBioLab

261780 · KOSDAQ · Health Care · SMALL CAP

A change of control.

AriBioLab's controlling stake is set to change hands from CHA Biotech to Solux Co., Ltd.

Ownership change(Share transfer agreement that will change the largest shareholder)· FILED 2026-03-19· RCEPT 20260319900021

US$15.8MDeal value

Converted at 1 USD ≈ ₩1,505.25 (filing-date rate, 2026-03-19 close)

What happened

AriBioLab's controlling stake is set to change hands from CHA Biotech to Solux Co., Ltd. and 3 others, in a deal worth US$15.8M.

A change of the controlling shareholder can reshape a company's strategy, capital allocation, and board.

FromCHA Biotech
ToSolux Co., Ltd. and 3 others
Deal valueUS$15.8M
Filed2026-03-19, Share transfer agreement that will change the largest shareholder
SourceDART rcept 20260319900021 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-03-19 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.